WJ-39

N/A

Report date: 2023/02/26 21:49:41
NME

Base Information

Drug NameWJ-39
Drug Alias NameWJ-39
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAldose reductase inhibitorsNuclear factor erythroid 2-related factor 2 stimulants
TargetsAldose reductaseNuclear factor erythroid 2-related factor 2
Therapy Area/IndicationsDiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesKangya Of Ningxia Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesKangya Of Ningxia Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetic Nephropathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A